EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis

Leman Arslan Ariturk, Sumeyye Cilingir, Meltem Kolgazi, Merve Elmas, Serap Arbak, Hande Yapislar

European Journal of Nutrition · 2024-10 · 63 (7) · 2801-2813

DOI: 10.1007/s00394-024-03468-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nutrition, online erschienen am 06.08.2024. Verfasst von Leman Arslan Ariturk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Physiology, Marmara University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Rats, Wistar, Colitis, Oxidative Stress. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal disorders associated with significant morbidity and complications. This study investigates the therapeutic potential of docosahexaenoic acid (DHA) in a trinitrobenzene sulfonic acid (TNBS) induced colitis model, focusing on inflammation, oxidative stress, and intestinal membrane permeability.

Methods

Wistar albino rats were divided into Control, Colitis, and Colitis + DHA groups (n = 8–10/group). The Colitis and Colitis + DHA groups received TNBS intrarectally, while the Control group received saline. DHA (600 mg/kg/day) or saline was administered via gavage for six weeks. Macroscopic and microscopic evaluations of colon tissues were conducted. Parameters including occludin and ZO-1 expressions, myeloperoxidase (MPO) activity, malondialdehyde (MDA), glutathione (GSH), total antioxidant status (TAS), total oxidant status (TOS), Interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α) levels were measured in colon tissues.

Results

Colitis induction led to significantly higher macroscopic and microscopic damage scores, elevated TOS levels, reduced occludin and ZO-1 intensity, decreased mucosal thickness, and TAS levels compared to the Control group (p < 0.001). DHA administration significantly ameliorated these parameters (p < 0.001). MPO, MDA, TNF-α, and IL-6 levels were elevated in the Colitis group but significantly reduced in the DHA-treated group (p < 0.001 for MPO, MDA; p < 0.05 for TNF-α and IL-6).

Conclusion

DHA demonstrated antioxidant and anti-inflammatory effects by reducing reactive oxygen species production, enhancing TAS capacity, preserving GSH content, decreasing proinflammatory cytokine levels, preventing neutrophil infiltration, reducing shedding in colon epithelium, and improving gland structure and mucosal membrane integrity. DHA also upregulated the expressions of occludin and ZO-1, critical for barrier function. Thus, DHA administration may offer a therapeutic strategy or supplement to mitigate colitis-induced adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsRats, WistarColitisOxidative StressAnimalsRatsDisease Models, AnimalMaleTrinitrobenzenesulfonic AcidColonInflammationPeroxidaseMalondialdehydeZonula Occludens-1 ProteinIntestinal MucosaAntioxidantsOccludinTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

DHAExperimental colitisIBDInflammationIntestinal barrier

Substanzen

Docosahexaenoic AcidsTrinitrobenzenesulfonic AcidPeroxidaseMalondialdehydeZonula Occludens-1 ProteinAntioxidantsOccludinTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Physiology, Marmara University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Physiology, Acibadem Mehmet Ali Adinlar University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Histology&Embriology, Acibadem Mehmet Ali Adinlar University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Physiology, Acibadem Mehmet Ali Adinlar University, Istanbul, Turkey. handeyapislar@gmail.com.

Förderung

  • Scientific and Technological Research Council of Turkey

Zitieren

APA

Ariturk, L. A., Cilingir, S., Kolgazi, M., Elmas, M., Arbak, S., & Yapislar, H. (2024). Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis. European Journal of Nutrition, 63(7), 2801-2813. https://doi.org/10.1007/s00394-024-03468-x

Vancouver

Ariturk LA, Cilingir S, Kolgazi M, Elmas M, Arbak S, Yapislar H. Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis. European Journal of Nutrition. 2024;63(7):2801-2813. doi:10.1007/s00394-024-03468-x

BibTeX
@article{Ariturk2024,
  author = {Ariturk, Leman Arslan and Cilingir, Sumeyye and Kolgazi, Meltem and Elmas, Merve and Arbak, Serap and Yapislar, Hande},
  title = {Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis},
  journal = {European Journal of Nutrition},
  year = {2024},
  volume = {63},
  number = {7},
  pages = {2801--2813},
  doi = {10.1007/s00394-024-03468-x}
}
Kostenlos starten →